Results from this study are similar to other reports where compound heterozygosity for Hb Adana with nondeletional mutations produce HbH disease with more severe anaemia, earlier presentation and possible blood transfusion requirements when compared with the less severe disorders of deletional HbH disease3, 6, 18. This evidence concerns the gene HBA2 and hemoglobin H disease.